THE IMPACT OF H YPOTHALAMIC-PITUITARY-ADRENAL SYSTEM HORMONES ON EPILEPTOGENESIS
https://doi.org/10.17650/2073-8803-2017-12-1-47-55
Abstract
Some issues concerning the impact of hypothalamic-pituitary-adrenal system (HPAS) hormones on epileptogenesis are discussed in the article. It was found, that they have a direct and indirect impact. Direct effect implies the reduction of excitation level in the brain cells by affecting membrane channels and receptors involved in the regulation of certain neurotransmitters synthesis. Indirect effect is realized through positive influence on the brain neurons maturation process, leveling the stimulation of excitation processes mediated by biologically active substances, ions and other agents. Adrenocorticotropic hormone and glucocorticosteroids are the main hormones used in antiepileptic therapy. They have an impact both on epileptogenesis itself, and on induction/inhibition of their own effects in accordance with a feedback mechanism of hormones secretion. The mechanism of antiepileptic action of HPAS hormones allows considering them as true antiepileptic drugs for treatment of drug-resistant and special forms of epilepsy.
About the Authors
L. V. Shalkevich
Belarusian Medical Academy of Postgraduate Education
Belarus
3/3 P. Brovka St., Minsk 220013, Republic of Belarus
Belarus
3/3 P. Brovka St., Minsk 220013, Republic of Belarus
A. I. Kudlach
Belarusian Medical Academy of Postgraduate Education
Belarus
3/3 P. Brovka St., Minsk 220013, Republic of Belarus
Belarus
3/3 P. Brovka St., Minsk 220013, Republic of Belarus
O. P. Nazarova
Republican Research and Clinical center of Neurology and Neurosurgery
Belarus
24 F. Skorina St., Minsk 220114, Republic of Belarus
Belarus
24 F. Skorina St., Minsk 220114, Republic of Belarus
References
1. Айвазян С.О., Лукьянова Е.Г., Ширяев Ю.С. Современные возможности лечения фармакорезистентной эпилепсии у детей. Эпилепсия и пароксизмальные состояния 2014;6(1):34–43. [Ayvazyan S.O., Luk’yanova E.G., Shiryaev Yu.S. Modern treatment options for drug-resistant epilepsy in children. Epilepsiya i paroksizmal’nye sostoyaniya = Epilepsy and Paroxysmal States 2014;6(1):34–43. (In Russ.)].
2. Звонкова Н.Г., Балканская С.В., Каркашадзе М.З. и др. Альтернативные методы лечения эпилепсии у детей. Вопросы современной педиатрии 2005;4(4):28–32. [Zvonkova N.G., Balkanskaya S.V., Karkashadze M.Z. et al. Alternative methods of treatment of epilepsy in children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2005;4(4): 28–32. (In Russ.)].
3. Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: Арт- Сервис Лтд, 2011. 680 с. [Mukhin K.Yu., Petrukhin A.S., Kholin A.A. Epileptic encephalopaties and similar syndromes in children. Moscow: ArtService Ltd, 2011. 680 p. (In Russ.)].
4. Студеникин В.М., Звонкова Н.Г., Боровик Т.Э. и др. Кетогенная диета при эпилепсии у детей. Вопросы современной педиатрии 2004;1(3): 47–52. [Studenikin V.M., Zvonkova N.G., Borovik T.E. et al. Ketogenic diet in epileptic children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2004;1(3):47–52. (In Russ.)].
5. Физиология эндокринной системы. Пер. с англ. Под ред. Дж. Гриффина, С. Охеды. М.: Бином. Лаборатория знаний, 2008. 496 с. [Physiology of the endocrine system. Transl. from Engl. Eds. by J. Griffin, S. Ojeda. Moscow: Binom. Laboratoriya znanii, 2008. 496 p. (In Russ.)].
6. Шалькевич Л.В., Шанько Г.Г., Кот Д.А. Кортикостероидная терапия фармакорезистентных эпилепсий у детей. Международный неврологический журнал 2014;3(65):20–7. [Shal’kevich L.V., Shan’ko G.G., Kot D.A. Corticosteroid therapy of drug- resistant epilepsies in children. Mezhdunarodnyy nevrologicheskiy zhurnal = International Neurological Journal 2014;3(65):20–7. (In Russ.)].
7. Aicardi J. Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol 1988;30:429–40. PMID: 3049187.
8. Aldenhoff J.B., Gruol D.L., Rivier J. et al. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983;221(4613):875–7. PMID: 6603658.
9. Ardeleanu A., Sterescu N. RNA and DNA synthesis in developing rat brain: hormonal influences. Psychoneuroendocrinol 1978;3(1):93–101. PMID: 2055895.
10. Avishai-Eliner S., Yi S.J., Baram T.Z. Developmental profile of messenger RNA for corticotropin-releasing hormone in the rat limbic system. Brain Res Dev Brain Res 1996;91(2):159–63. PMID: 8852365.
11. Baram T.Z., Hatalski C.G. Neuropeptidemediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21(11):471–6. PMID: 9829688.
12. Brunson K.L., Avishai-Eliner S., Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185–97. PMID: 12040892.
13. Dumermuth G. Uber die Blitz-Nick-Salaam-Krampfe und ihre Behandlung mit ACTH und hydrocortison. Vorlaufige Mitteilung. Helv Paediatr Acta 1959;14:250–70. PMID: 13818581.
14. Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. In: Purinergic approaches in experimental therapeutics. Eds. by K.A. Jacobson, M.F. Jarvis. New York: Wiley Liss, 1997. Pp. 359–382.
15. Gastaut H., Saltiel J., Raybaud C. et al. A propos du traitement par l’ACTH des encephalites myoclonique de la premiere enfance avec majeure (hypsarhythmia). Pediatrie 1959;14(1):35–41. PMID: 13633380.
16. Giorgi F.S., Pizzanelli C., Biagioni F. et al. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev 2004;28(5):507–24. DOI: 10.1016/j.neubiorev.2004.06.008. PMID: 15465138.
17. Haas H.L., Greene R.W. Endogenous adenosine inhibits hyppocampal CA1 neurones: further evidence from extra- and intracellular recording. Naunyn-Schmiedeberg’s Arch Pharmacol 1988;337(5):561–5. PMID: 3412493.
18. Hollrigel G.S., Chen K., Baram T.Z. et al. The pro-convulsant actions of corticotropin- releasing hormone in the hippocampus of infant rats. Neurosci 1998;84(1):71–9. PMID: 9522363.
19. Huttenlocher P.R., Amemiya I.M. Effect of adrenocortical steroids and of adrenocorticotrophic hormone on (Na+/K+)- ATP-ase in immature cerebral cortex. Pediatr Res 1978;12(2):104–7. DOI: 10.1203/00006450-197802000-00008. PMID: 205825.
20. Iacobas D.A., Iacobas S., Chachua T. et al. Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms. J Neuroendocrinol 2013;25(11):964–79. DOI: 10.1111/jne.12061. PMID: 23763471.
21. Irani S.R., Buckley C., Vincent A. et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008;71(20):1647–8. DOI: 10.1212/01.wnl.0000326572.93762.51. PMID: 18815385.
22. Jarvis M.F., Williams M. Adenosine in central nervous system function. In: Adenosine and adenosine receptors. Ed. by M. Williams. Clifton: The Humana Press, 1990. Pp. 423–474.
23. Klein R., Livingston S. The effect of adrenocorticotrophic hormones in epilepsy. J Pediatr 1950;37(5):733–42. PMID: 14784927.
24. Low N.L. Infantile spasms with mental retardation. II. Treatment with cortisone and adrenocorticotropin. Pediatrics 1958;22(6):1165–9. PMID: 13613851.
25. Marver D. Evidence of corticosteroid action along the nephron. Am J Physiol 1984;246(2):111–23. PMID: 6320678.
26. McKnight K., Jiang Y., Hart Y. et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurol 2005;65(11):1730–6. DOI: 10.1212/01.wnl.0000187129.66353.13. PMID: 16344514.
27. McQuarrie I., Anderson J.A., Ziegler M.R. Observation on the antagonistic effects of posterior pituitary and cortico-adrenal hormones in the epileptic subject. J Clin Endocrinol 1942;2: 406–10.
28. Munakata M. et al. Reduction in glutamine/glutamate levels in the cerebral cortex after adrenocorticotropic hormone therapy in patients with West syndrome. Tohoku J Exp Med 2014;232(4):277–83. PMID: 24705707.
29. Molteni R., Fumagalli F., Magnaghi V. et al. Modulation of fibroblast growth factor- 2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev 2001;37 (1–3):249–58. PMID: 11744090.
30. O’Regan M.E., Brown J.K. Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 1998;40(2):82–9. PMID: 9489495.
31. Palo J., Savolainen H. The effect of high doses of synthetic ACTH on rat brain. Brain Res 1974;70(2):313–20. PMID: 4363491.
32. Prazantelli M.R. On the molecular mechanism of adrenocorticotropic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125(1):142–61. DOI: 10.1006/exnr.1994.1018. PMID: 7905835.
33. Riikonen M.R., Soderstrom S., Vanhala R. et al. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17(3):224–9. PMID: 9390698.
34. Sorel L., Dusaucy-Bauloye A. A propos de 21 cas d’hypsarhythmie de Gibbs: son traitement spectaculaire par I'ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130. PMID: 13532578.
35. Stamps F.W., Gibbs E.L., Rosenthal I.M. et al. Treatment of hypsarrhythmia with ACTH. J Am Med Assoc 1959;171: 408–11. PMID: 13833723.
36. Storm van Leeuwen W., Lopes da Silva F.H., de Weid D. A frequency shift in the hippocampal teta activity: an electrical correlate of central action of ACTH analogues in the dog? Brain Res 1974;69(2):361–5. PMID: 4362816.
37. Urban I., de Weid D. Changes in excitability of the theta generating substrate by ACTH 4–10 in the rat. Exp Brain Res 1976;24:325–34. PMID: 176046.
38. Vaughan C.J., Delanty N. Pathophysiology of acute symptomatic seizures. In: Seizures: Medical Causes and Management. Ed. by N. Delanty. The Humana Press: Totowa, NJ, 2002. Pp. 7–24.
39. Vreugdenhil E., de Kloet E.R., Schaaf M. et al. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol 2001;11(6):423–30. PMID: 11704419.
40. Weissmann G., Thomas L. Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest 1963;42(5):661–9. DOI: 10.1172/JCI104757. PMID: 13999782.
41. Zhang Y., Zou L.P., Ding Y.X. et al. Association of SCN1A gene polymorphisms with infantile spasms and adrenocorticotropic hormone responsiveness. Eur Rev Med Pharmacol Sci 2014;18(17):2500–6. PMID: 25268096.
Review
For citations:
Shalkevich L.V., Kudlach A.I., Nazarova O.P. THE IMPACT OF H YPOTHALAMIC-PITUITARY-ADRENAL SYSTEM HORMONES ON EPILEPTOGENESIS. Russian Journal of Child Neurology. 2017;12(1):47-55. (In Russ.) https://doi.org/10.17650/2073-8803-2017-12-1-47-55
Views:
4386
Email this article 